ptcbio.com

Please wait for loading...




      (27):

    /
     4  +18 2014 feb 28therapeuticsPTC Therapeutics : HomeFocused on the discovery and commercialization of orally active small molecule therapeutics for human diseases.
     8  ~ 2014 feb 13cytoric terapeuticsPTC Therapeutics , Inc. - Historic Stock LookupTherapeutic Areas · Genetic Disorders · Oncology
     11  +1 2014 mar 01therapeutics inc2/28/2014PTC Therapeutics To Present At The Cowen & Company 34th Annual ... 2/27/2014PTC Therapeutics Reports Inducement Grant Under Nasdaq Listing   ...
     13  ~ 2014 feb 17ptc indexptc therapeutics to join russell 2000 index - Investor Relations"We are very pleased to be included in the Russell 2000® Index ," stated Stuart W . Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc.
     15  +31 2014 mar 01ptc emailPTC Therapeutics: CareersAt PTC Therapeutics we are looking at drug discovery and development in a whole ... If you are interested in employment with PTC Therapeutics, please email   ...
     18  +5 2014 feb 13does ptc sense workPTC Therapeutics: Culture and ValuesSENSE OF URGENCY — We do today what can be done today. ... We are committed to our work , strive to consistently meet deadlines and apply pride and   ...
     20  +7 2014 jan 24ptc phone numberPTC Therapeutics: Location & DirectionsLocation Information PTC Therapeutics Inc. 100 Corporate Court South Plainfield , NJ 07080-2449. Phone :908-222-7000. Fax: 908-222-7231 info@ ptcbio .com.
     21  +25 2014 jan 28ptc en venezuelaPTC Therapeutics: Contact UsIf you would like to subscribe to receive PTC updates, please enter your preferences below: PTC Corporate Updates (All company financial, clinical or research  ...
     22  +79 2014 feb 06nonsense mutationPTC Therapeutics: AtalurenAtaluren (PTC124) is an investigational new drug by PTC Therapeutics in clinical trials in patients with nonsense mutation genetic disorders.
     30  +45 2014 feb 21new ptc'sPTC Therapeutics: HomePTC applies its expertise in RNA biology and drug development to pioneer novel ... Ataluren (PTC124®) is an investigational new drug designed to enable the  ...
     30  ~ 2014 jan 31american ptc sitesptc therapeutics to present at the north american cystic fibrosis PTC THERAPEUTICS TO PRESENT AT THE NORTH AMERICAN ... For more information, visit the company's web site at www. ptcbio .com.
     34  +37 2013 dec 22ptc website for saleFocused on the discovery and commercialization of orally active small molecule therapeutics for human diseases.
     40  +23 2014 feb 11ptc investigatorPTC Therapeutics: DMD Clinical Trial SitesBelow is a list of countries where there is a trial site for the Phase 3 clinical trial of ataluren in patients with nonsense mutation Duchenne muscular dystrophy  ...
     45  ~ 2014 jan 25press release summaryPTC Therapeutics, Inc. - Press ReleasesView Summary , PTC THERAPEUTICS PROVIDES UPDATE ON CHMP OPINION FOR CONDITIONAL APPROVAL OF ATALUREN FOR NONSENSE  ...
     47  -6 2014 feb 28russell 2000 index"We are very pleased to be included in the Russell 2000 ® Index ," stated Stuart W . Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc.
     52  +12 2014 jan 08ptc site submissionPTC Therapeutics Reports Second Quarter ... - Investor RelationsThe Phase 3 study is expected to be conducted at 53 clinical sites ... In July 2013, PTC submitted responses to the Day 120 Questions to the  ...
     53  +2 2013 dec 16protein synthesis wordPTC Therapeutics: RNA BiologyTo ensure that the appropriate proteins are always synthesized in the correct cells ... Initiation, the selection of the start site, is delineated by a unique code word   ...
     60  ~ 2014 feb 16royal ptc
     67  ~ 2014 feb 28ptc wikiPTC Therapeutics: About UsPTC Therapeutics, Inc. ( PTC ) is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule  ...
     70  ~ 2013 dec 27south plainfield websiteClinical Trials · Ataluren · Investor Relations. ©2013 PTC Therapeutics. All rights reserved. built@zoomedia. SHARE THIS PAGE: Show Site Map.
     80  -54 2014 feb 21pt cPTC applies its expertise in RNA biology and drug development to pioneer novel oral treatments for patients living with serious and life-threatening conditions.
     86  +15 2014 jan 23becker muscular dystrophyAdvanced Duchenne/ Becker Muscular Dystrophy Genetic TestingGenetic Testing for Duchenne and Becker Muscular Dystrophy . Genetic tests find changes, called mutations, in genes that cause disease. These tests can be a  ...
     90  -19 2013 dec 25common genetic disordersPTC Therapeutics: Genetic DisordersCystic fibrosis is among the most common life-threatening genetic disorders worldwide. Cystic fibrosis is caused by defects in a single gene known as the cystic  ...
     94  ~ 2014 jan 27facebook press releaseATALUREN CLINICAL DATA DEMONSTRATE AN INCREASE IN Any statements in this press release about future expectations, plans and prospects for the Company, the development of and potential market  ...
     95  +6 2014 jan 09genetic background testingAdvanced Duchenne/Becker Muscular Dystrophy Genetic TestingGenetic Testing for Duchenne and Becker Muscular Dystrophy. Genetic tests find changes, called mutations, in genes that cause disease. ... Background
     96  ~ 2014 jan 14jp morgan conferencePTC Therapeutics to Present at the JP Morgan Healthcare ConferencePTC Therapeutics to Present at the J.P. Morgan Healthcare Conference . SOUTH PLAINFIELD, NJ – January 6, 2014 – PTC Therapeutics, Inc.
     98  -9 2013 dec 21update new ptc
    1 of 1 pages